Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder
- Conditions
- Alcohol Use Disorder
- Interventions
- Device: Low Intensity Focused Ultrasound
- Registration Number
- NCT06518785
- Lead Sponsor
- University of California, San Francisco
- Brief Summary
This study aims to examine the effects of Low-Intensity Focused Ultrasound (LIFU) on brain activity in patients with alcohol use disorder.
- Detailed Description
This is a single-center, double-blind, controlled, randomized, complete block, 2-period crossover pilot trial. The study will assess target engagement of the ventral striatum after LIFU in patients with alcohol use disorder using resting state and task-based functional magnetic resonance imaging (fMRI).
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 25
- Male or female ≥ 18 years of age.
- Documentation of an AUD diagnosis per DSM-5 criteria as evidenced by problematic pattern of alcohol use leading to clinically significant impairment or distress, as manifested by at least two of the DSM-5 criteria, occurring within a 12-month period.
- Be willing to undergo a brain MRI and follow study protocol.
- Pregnant or breastfeeding.
- Presence of a condition or abnormality that would compromise the safety of the patient or the quality of the data.
- Non-English speaking.
- Other investigational AUD treatments.
- Primary psychosis, Bipolar I, or severe personality disorder.
- Active suicidality or history of suicide attempt in the past 5 years.
- Cognitive impairment (MoCA <24)
- Significant medical or neurological disease, or life expectancy <12 mos.
- Significant brain abnormality on brain imaging.
- Any MRI exclusion criteria.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description VS LIFU/ VPL LIFU Low Intensity Focused Ultrasound Participants will be assigned to receive VS LIFU during the first LIFU treatment session. VPL LIFU/VS LIFU Low Intensity Focused Ultrasound Participants will be assigned to receive VPL LIFU during the first LIFU treatment session.
- Primary Outcome Measures
Name Time Method Reward network activity in response to alcohol cues. 3 visits over 3 weeks Reward network activity in response to alcohol vs. neutral cues before and after LIFU will be assessed using fMRI.
Incidence of LIFU-related adverse events. Through study completion, an average of 5 weeks This will be assessed through monitoring for adverse events (AE) throughout the study.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of California, San Francisco
🇺🇸San Francisco, California, United States